Intuitive Surgical (ISRG) is out with preliminary Q4 and FY13 results.
Q4: Revenue seen at $576M (-5% Y/Y), consensus is $548.6M; instruments and accessories revenue, $268M (+6% Y/Y); da Vinci Surgical Systems revenue seen at $205M (-23% Y/Y); systems sold, 138 versus 175 in Q4 2012.
FY13: Revenue seen at ~$2.265B (+4% Y/Y), consensus is $2.24B; instruments and accessories revenue, $1.033B (+14% Y/Y); da Vinci Surgical Systems revenue see at $835M (-11%), systems sold, 546 versus 620 in 2012. (PR)
Summer Street's Mark Land is reportedly cautious, noting that the seasonality of elective procedures may have contributed to Q4 results.
ISRG +12% premarket.